Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Human Microbiome Market to Grow at a CAGR of 17% by 2022: Analysis By Disease, Application & Product - Research and Markets

Research and Markets
Posted on: 24 Aug 17

The "Human Microbiome Market - Forecasts from 2017 to 2022" report has been added to Research and Markets' offering.

Human Microbe market is expected to grow at a CAGR of 17.05% over the forecast period to grow to US$635.829 million by 2022, growing from US$289.411 million in 2017.

Major factors responsible for global human microbiome market growth are increasing instances of life style diseases, diarrhoeal infections, predominant changes in the life style of the global population and increase in aged population. Moreover, technological enhancements in biomedical sciences and growing research investment in technology and product sectors also impact the market growth positively. However, lack of awareness about the use and advantage of prebiotics and probiotics and government restrictions on their usage may impair the market growth.

Geographically, North America would contribute considerably to the market growth of human microbes on account of the expansion of health care industry and strengthening of medical infrastructure. Moreover, increased investments by leading players will also impact the market growth. Europe is also expected to drive the market growth on account of investments by private players and government.

Companies Mentioned

  • Seres Therapeutics
  • Microbiome Therapeutics, LLC
  • uBiome, Inc
  • Second Genome
  • Vedanta Biosciences
  • Blue Turtle Bio
  • Metabiomics
  • Rebiotix Inc.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

5. Global Human Microbiome Market Forecast by Disease (US$ billion)

6. Global Human Microbiome Market Forecast by Application (US$ billion)

7. Global Human Microbiome Market Forecast by Product (US$ billion)

8. Americas

9. Competitive Intelligence

10. Company Profiles

For more information about this report visit

View source version on

Business Wire

Last updated on: 24/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.